Viewing StudyNCT06460961



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06460961
Status: RECRUITING
Last Update Posted: 2024-06-14
First Post: 2024-06-11

Brief Title: A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With AdvancedMetastatic Solid Tumors MK-6837-001
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Conditions & Keywords Data

Conditions:
Name
Neoplasm Metastasis
Keywords:
Name View
Programmed Cell Death-1 PD1 PD-1 View
Programmed Cell Death 1 Ligand 1 PDL1 PD-L1 View
Programmed Cell Death 1 Ligand 2 PDL2 PD-L2 View